Joanne Jenkins Lager M.D.
Net Worth

Last updated:

What is Joanne Jenkins Lager M.D. net worth?

The estimated net worth of Dr. Joanne Jenkins Lager M.D. is at least $4,964,113 as of 11 Mar 2022. He owns shares worth $15,377 as insider, has earned $2,126,496 from insider trading and has received compensation worth at least $2,822,240 in iTeos Therapeutics, Inc..

What is the salary of Joanne Jenkins Lager M.D.?

Dr. Joanne Jenkins Lager M.D. salary is $705,560 per year as Chief Medical Officer in iTeos Therapeutics, Inc..

How old is Joanne Jenkins Lager M.D.?

Dr. Joanne Jenkins Lager M.D. is 54 years old, born in 1971.

What stocks does Joanne Jenkins Lager M.D. currently own?

As insider, Dr. Joanne Jenkins Lager M.D. owns shares in one company:

Company Title Shares Price per share Total value
iTeos Therapeutics, Inc. (ITOS) Chief Medical Officer 1,518 $10.13 $15,377

What does iTeos Therapeutics, Inc. do?

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.

ITOS logo
ITOS
iTeos Therapeutics, Inc.
$10.13

Joanne Jenkins Lager M.D. insider trading

iTeos Therapeutics, Inc.

Dr. Joanne Jenkins Lager M.D. has made 8 insider trades between 2021-2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 28,000 units of ITOS stock on 18 Nov 2021. As of 11 Mar 2022 he still owns at least 1,518 units of ITOS stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 3,500 $4.3 $15,050
Option
Stock Option (Right to Buy) 3,500 $4.3 $15,050
Sale
Common Stock 3,500 $36.01 $126,035
Sale
Common Stock 1,982 $35.52 $70,401
Option
Common Stock 3,500 $4.3 $15,050
Sale
Common Stock 1,518 $36.27 $55,058
Option
Stock Option (right to buy) 3,500 $4.3 $15,050
Option
Common Stock 3,500 $4.3 $15,050
Option
Stock Option (Right to Buy) 3,500 $4.3 $15,050
Sale
Common Stock 3,500 $39.42 $137,953
Sale
Common Stock 7,000 $51.9 $363,300
Option
Stock Option (Right to Buy) 7,000 $4.3 $30,100
Option
Common Stock 7,000 $4.3 $30,100
Option
Stock Option (right to buy) 7,000 $4.3 $30,100
Option
Common Stock 7,000 $4.3 $30,100
Sale
Common Stock 7,000 $41 $287,000
Option
Stock Option (right to buy) 3,500 $4.3 $15,050
Option
Common Stock 3,500 $4.3 $15,050
Sale
Common Stock 3,500 $34.5 $120,750
Option
Common Stock 28,000 $4.3 $120,400
Sale
Common Stock 28,000 $34.5 $966,000
Option
Stock Option (right to buy) 28,000 $4.3 $120,400

iTeos Therapeutics key executives

iTeos Therapeutics, Inc. executives and other stock owners filed with the SEC: